Look for:

Products

BIO-RAD LABORATORIES INC.


ISIN:
US0905722072
WKN:
090572207

2024/04/26 22:00:02
Price
275.94 USD
Difference 0.12% (0.34)

General attributes

ISINUS0905722072
SymbolBIO
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)6,025 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)265.80 USD (200)
Ask (Ask size)307.50 USD (100)
Open275.27 USD
High279.77 USD
Low274.91 USD
Close (prev. day)275.60 USD
VWAP276.627604 USD
Volume (pcs)179,207
Trading volume49,589,923.28
Number of trades7,768
Last size-

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: BIO-RAD LABORATORIES INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/04/26 22:00:02
Price
275.94 USD
Difference 0.12% (0.34)

General attributes

ISINUS0905722072
SymbolBIO
ExchangeNYSE
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)6,025 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)265.80 USD (200)
Ask (Ask size)307.50 USD (100)
Open275.27 USD
High279.77 USD
Low274.91 USD
Close (prev. day)275.60 USD
VWAP276.627604 USD
Volume (pcs)179,207
Trading volume49,589,923.28
Number of trades7,768
Last size-

Performance and Risk

6m1Y3Y
Perf (%)-5.35%-36.71%-57.44%
Perf (abs.)-15.59-160.06-372.40
Beta1.100.730.96
Volatility30.2435.0335.14
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)279.03 USD (204,143)
Ø price 30 days | Ø volume 30 days (pcs.)317.06 USD (197,996)
Ø price 100 days | Ø volume 100 days (pcs.)320.85 USD (219,849)
Ø price 250 days | Ø volume 250 days (pcs.)346.40 USD (226,600)
YTD High | date364.24 USD (2024/02/16)
YTD Low | date268.92 USD (2024/04/18)
52 Weeks High | date473.50 USD (2023/05/03)
52 Weeks Low | date261.59 USD (2023/10/30)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Tradegate2024/04/2622:26257.80 EUR0.001
Stuttgart2024/04/2617:47258.30 EUR0.005
NYSE2024/04/2622:00275.94 USD49.597,768
Munich2024/04/2608:03258.60 EUR0.002
Frankfurt2024/04/2608:20256.30 EUR0.002
Duesseldorf2024/04/2619:30259.00 EUR0.007
Berlin2024/04/2608:08256.30 EUR0.002

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=114980&ID_TYPE_IMAGE_LOGO=2

Contact Details

BIO-RAD LABORATORIES INC.
- -
1000 Alfred Nobel Drive - 94547 Hercules
Telefon: +1-510-724-7000
Fax: +1-510-741-5817
E-mail: ask_customer_care@bio-rad.com

PDF Downloads

Company report: BIO-RAD LABORATORIES INC.PDF Download

Company Profile

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Members of Management Board

Alice SchwartzMember of Board of Directors
Allison SchwartzMember of Board of Directors
Arnold PinkstonMember of Board of Directors
Gregory HinckleyMember of Board of Directors
Jeffrey EdwardsMember of Board of Directors
Melinda LitherlandMember of Board of Directors
Norman SchwartzChairman of Managing Board
Ajit RamalingamMember of Executive Committee
Andrew LastMember of Executive Committee
Annette TumoloMember of Executive Committee
Dara WrightMember of Executive Committee
Ilan DaskalMember of Executive Committee
Mike CrowleyMember of Executive Committee
Timothy ErnstMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended), citizen/resident of Australia, Canada, Great Britain and Japan. For this reason, the distribution or redistribution of the information, materials and products into United States, Australia, Canada, Great Britain and Japan or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited.

The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.